Abstract
BackgroundType I Interferon (IFN) pathway is activated in Systemic Sclerosis (SSc) and represents a therapeutic target currently being tested in clinical trials, while higher IFNα levels have been also associated...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have